Search results
Results from the WOW.Com Content Network
Bio Products Laboratory Limited [1] (BPL) is a company involved in the manufacture of human blood plasma products, located in Elstree, Hertfordshire, England. It is run as a commercial business and supplies plasma derived products to the National Health Service in the UK as well as to markets in over 45 countries.
BSP Financial Group Limited (BSP) is the largest bank in Papua New Guinea, with 121 branches throughout the country and in 7 countries. BSP currently services over 650,000 business banking customers throughout the Pacific. [ 2 ]
Beiersdorf – Beiersdorf UK Ltd; Berk – TEVA UK Ltd; Biogen – Biogen Idec; Boehringer Ingelheim – Boehringer Ingelheim Ltd; Boots – Boots Group (Medical Services) BPL – Bio Products Laboratory; Braun – B. Braun Melsungen (Medical) Ltd; Bristol-Myers Squibb – Bristol-Myers Squibb Pharmaceuticals Ltd; Celltech – UCB Pharma Ltd ...
In the fall of 2011 the Sanofi Pasteur plant flooded, causing problems with mold. [7] The facility, located in Toronto, Ontario, Canada, produced BCG vaccine products made with the Glaxo 1077 strain, [8] such as a tuberculosis vaccine and ImmuCYST, a BCG immunotherapeutic and bladder cancer drug.
BPL Ltd has reported a net loss of ₹ 34.76 crore (equivalent to ₹ 112 crore or US$13 million in 2023) in the second quarter of fiscal 2005-06, on gross sales of ₹ 34.71 crore (equivalent to ₹ 111 crore or US$13 million in 2023).
In 1996, the company acquired UDL Laboratories, a supplier of unit dose generic medications to institutional and long-term care facilities. [ 34 ] In 1998 when it was the world's second largest generics company, the company came under investigation from the Federal Trade Commission after it raised the prices of its products, tripling them in ...
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. [ 5 ] [ 6 ] [ 2 ] [ 7 ] The company manufactures and custom synthesizes generic APIs, intermediates.
The Beecham Group plc was a British pharmaceutical company.It was once a constituent of the FTSE 100 Index.Founded by Thomas Beecham who opened the first factory in St Helens, Lancashire in 1859, Beecham focused on marketing the business by advertising in newspapers and using a network of wholesale agents in northern England and in London, rapidly building up the business. [1]